Companies / Celea Therapeutics
Celea Therapeutics
Boston, Massachusetts, United States
Celea Therapeutics is developing therapies for serious respiratory diseases, including a treatment for idiopathic pulmonary fibrosis
Celea Therapeutics, based in Boston, Massachusetts, United States, has 1 investor on file, among them RA Capital. Its latest round on record is Series C+, 1 Jul 2026. Its site was last checked 14 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Page + round | Venture capital |
More from RA Capital
222 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (91%), Climate & Energy (4%), Advanced Materials & Chemicals (3%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Celea Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when RA Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/celeatx.com/investors
# also
GET /v1/companies/celeatx.com
GET /v1/companies/celeatx.com/news